Hitoshi Iwasaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hitoshi Iwasaki has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Shinichi Aishima
Department of Scientific Pathology Graduate School of Medical Sciences Kyushu University Fukuoka Japan
2 shared publications - Shinji Itoh
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan
2 shared publications - Shohei Yoshiya
Department of Surgery and Science, Graduate School of Medical Sciences Kyushu University Fukuoka Japan
2 shared publications - Takeo Toshima
Department of Surgery and Science, Graduate School of Medical Sciences Kyushu University Fukuoka Japan
2 shared publications - Tomoharu Yoshizumi
Department of Surgery and Science Graduate School of Medical Sciences Kyushu University Fukuoka Japan
2 shared publications - Yoshinao Oda
Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
2 shared publications
Latest Publications
- 28 August 2026
- Published by Wiley in Hepatology Research
Nuclear Pan‐Lysine Lactylation Immunoreactivity Is Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma
Aim: Lysine lactylation (Kla) links cellular metabolism to gene regulation, but its significance in intrahepatic cholangiocarcinoma (ICC) remains unclear. Methods: Nuclear pan‐Kla immunoreactivity was evaluated in 118 patients who underwent curative‐intent resection for ICC. Associations with clinicopathological features, overall survival (OS), recurrence‐free survival (RFS), and FDG‐PET‐derived SUVmax were analyzed. Functional assays and bulk RNA sequencing were performed in cholangiocarcinoma cells treated with lactate, the p300 inhibitor A‐485, or the LDH inhibitor oxamate. Results: High nuclear pan‐Kla immunoreactivity was associated with microscopic intrahepatic metastasis and poorer OS and RFS, and remained independently associated with both outcomes after multivariable adjustment. Adding Kla modestly increased the optimism‐corrected C‐index for OS, whereas RFS discrimination was not improved. Lactate increased pan‐Kla signals but produced minimal phenotypic and transcriptional changes. In contrast, p300 or LDH inhibition reduced pan‐Kla signals and was accompanied by reduced cell viability, colony formation, and wound closure; however, these effects cannot be attributed specifically to reduced Kla because A‐485 and oxamate are not Kla‐specific. RNA sequencing showed suppression of E2F target and G2M checkpoint programs. In an exploratory PET subgroup, the Kla H‐score correlated weakly with SUVmax, and patients with high Kla and high SUVmax had the poorest outcomes. Conclusions: Nuclear pan‐Kla immunoreactivity was independently associated with poor postoperative outcomes in resected ICC. Pharmacological modulation of lactylation‐related pathways was accompanied by suppression of proliferative and cell cycle‐related programs, although Kla‐specific causality remains to be established.
- 28 August 2026
- Published by Wiley in Hepatology Research
Nuclear Pan‐Lysine Lactylation Immunoreactivity Is Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma
Aim: Lysine lactylation (Kla) links cellular metabolism to gene regulation, but its significance in intrahepatic cholangiocarcinoma (ICC) remains unclear. Methods: Nuclear pan‐Kla immunoreactivity was evaluated in 118 patients who underwent curative‐intent resection for ICC. Associations with clinicopathological features, overall survival (OS), recurrence‐free survival (RFS), and FDG‐PET‐derived SUVmax were analyzed. Functional assays and bulk RNA sequencing were performed in cholangiocarcinoma cells treated with lactate, the p300 inhibitor A‐485, or the LDH inhibitor oxamate. Results: High nuclear pan‐Kla immunoreactivity was associated with microscopic intrahepatic metastasis and poorer OS and RFS, and remained independently associated with both outcomes after multivariable adjustment. Adding Kla modestly increased the optimism‐corrected C‐index for OS, whereas RFS discrimination was not improved. Lactate increased pan‐Kla signals but produced minimal phenotypic and transcriptional changes. In contrast, p300 or LDH inhibition reduced pan‐Kla signals and was accompanied by reduced cell viability, colony formation, and wound closure; however, these effects cannot be attributed specifically to reduced Kla because A‐485 and oxamate are not Kla‐specific. RNA sequencing showed suppression of E2F target and G2M checkpoint programs. In an exploratory PET subgroup, the Kla H‐score correlated weakly with SUVmax, and patients with high Kla and high SUVmax had the poorest outcomes. Conclusions: Nuclear pan‐Kla immunoreactivity was independently associated with poor postoperative outcomes in resected ICC. Pharmacological modulation of lactylation‐related pathways was accompanied by suppression of proliferative and cell cycle‐related programs, although Kla‐specific causality remains to be established.
- Open Access
- 7 August 2026
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 10 (9)
Spatiotemporal dynamics of the tumor microenvironment in hepatocellular carcinoma during combination immunotherapy
Background: Atezolizumab plus bevacizumab (ATZ/BEV) is a standard first-line therapy for advanced hepatocellular carcinoma (HCC); however, many patients do not achieve meaningful tumor regression. The temporal and spatial immune remodeling associated with ATZ/BEV remains poorly understood. Methods: We performed single-cell RNA sequencing of paired hepatectomy specimens obtained before and after ATZ/BEV from one patient and of tumor center and margin samples from another patient after ATZ/BEV. Cell composition, subclusters, and cell–cell communication were analyzed. In addition, candidate molecules identified by transcriptomic analysis were further assessed using serum-based assays and immunohistochemistry. Results: These single-cell analyses suggested that ATZ/BEV was associated with a shift toward an immune-active tumor microenvironment, with increased CD8 + T cells together with reduced endothelial cells. CD8 + T cells showed increased effector and exhaustion signatures, indicating coexistence of activation and dysfunction. CellChat analysis demonstrated selective activation of the TIGIT–PVR/NECTIN2 axis after treatment. Spatial analysis showed that the tumor margin was enriched for CD8 + T cells and exhibited stronger effector and exhaustion activity than the tumor center. Immunoregulatory signaling was also more prominent at the margin. Serum TIGIT levels were significantly higher after ATZ/BEV than in upfront resection cases ( p =0.0325). Immunohistochemistry showed greater margin-to-center differences in TIGIT ( p =0.0019) and PVR ( p =0.0008) in the tumor after ATZ/BEV. Conclusions: Our exploratory findings suggest that ATZ/BEV may remodel the HCC microenvironment toward a state characterized by concurrent CD8 + T-cell activation and inhibitory signaling through the TIGIT–PVR/NECTIN2 axis, particularly at the tumor margin.
- 7 August 2026
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 10 (9)
Open AccessSpatiotemporal dynamics of the tumor microenvironment in hepatocellular carcinoma during combination immunotherapy
Background: Atezolizumab plus bevacizumab (ATZ/BEV) is a standard first-line therapy for advanced hepatocellular carcinoma (HCC); however, many patients do not achieve meaningful tumor regression. The temporal and spatial immune remodeling associated with ATZ/BEV remains poorly understood. Methods: We performed single-cell RNA sequencing of paired hepatectomy specimens obtained before and after ATZ/BEV from one patient and of tumor center and margin samples from another patient after ATZ/BEV. Cell composition, subclusters, and cell–cell communication were analyzed. In addition, candidate molecules identified by transcriptomic analysis were further assessed using serum-based assays and immunohistochemistry. Results: These single-cell analyses suggested that ATZ/BEV was associated with a shift toward an immune-active tumor microenvironment, with increased CD8 + T cells together with reduced endothelial cells. CD8 + T cells showed increased effector and exhaustion signatures, indicating coexistence of activation and dysfunction. CellChat analysis demonstrated selective activation of the TIGIT–PVR/NECTIN2 axis after treatment. Spatial analysis showed that the tumor margin was enriched for CD8 + T cells and exhibited stronger effector and exhaustion activity than the tumor center. Immunoregulatory signaling was also more prominent at the margin. Serum TIGIT levels were significantly higher after ATZ/BEV than in upfront resection cases ( p =0.0325). Immunohistochemistry showed greater margin-to-center differences in TIGIT ( p =0.0019) and PVR ( p =0.0008) in the tumor after ATZ/BEV. Conclusions: Our exploratory findings suggest that ATZ/BEV may remodel the HCC microenvironment toward a state characterized by concurrent CD8 + T-cell activation and inhibitory signaling through the TIGIT–PVR/NECTIN2 axis, particularly at the tumor margin.
- Open Access
- 18 April 2024
- Published by Springer Nature in Surgical Case Reports
- Vol. 10 (1) , 1-7
Fatal pulmonary embolism after surgery for small intestinal necrosis caused by idiopathic portal vein thrombosis: a case report
Background: Portal vein thrombosis (PVT) and venous thromboembolism (VTE) both result from partial or complete occlusion of a blood vessel by a blood clot. The prognosis of PVT is generally good; however, PVT with VTE, including pulmonary embolism (PE), has a high mortality rate. We report here a case of PE after surgery for small intestinal necrosis caused by idiopathic PVT. Case presentation: A 69-year-old female attended our hospital with a chief complaint of upper abdominal discomfort, and was diagnosed with necrosis of the small intestine as a result of unexplained PVT. She underwent partial resection of the small intestine. On the second postoperative day, she suffered from respiratory distress and went into cardiopulmonary arrest. The patient recovered following cardiopulmonary resuscitation, but PE was detected. Extracorporeal veno-arterial cardiopulmonary resuscitation and anticoagulation therapy were initiated immediately and the thrombus was aspirated as much as possible. Two days later, extracorporeal veno-arterial cardiopulmonary resuscitation was withdrawn and anticoagulation therapy was continued. The patient subsequently recovered with no neurological damage and was discharged on day 26 after the above procedure. Conclusions: Idiopathic PVT is often associated with VTE, and a prompt diagnosis and intervention may result in a good prognosis.
- 18 April 2024
- Published by Springer Nature in Surgical Case Reports
- Vol. 10 (1) , 1-7
Open AccessFatal pulmonary embolism after surgery for small intestinal necrosis caused by idiopathic portal vein thrombosis: a case report
Background: Portal vein thrombosis (PVT) and venous thromboembolism (VTE) both result from partial or complete occlusion of a blood vessel by a blood clot. The prognosis of PVT is generally good; however, PVT with VTE, including pulmonary embolism (PE), has a high mortality rate. We report here a case of PE after surgery for small intestinal necrosis caused by idiopathic PVT. Case presentation: A 69-year-old female attended our hospital with a chief complaint of upper abdominal discomfort, and was diagnosed with necrosis of the small intestine as a result of unexplained PVT. She underwent partial resection of the small intestine. On the second postoperative day, she suffered from respiratory distress and went into cardiopulmonary arrest. The patient recovered following cardiopulmonary resuscitation, but PE was detected. Extracorporeal veno-arterial cardiopulmonary resuscitation and anticoagulation therapy were initiated immediately and the thrombus was aspirated as much as possible. Two days later, extracorporeal veno-arterial cardiopulmonary resuscitation was withdrawn and anticoagulation therapy was continued. The patient subsequently recovered with no neurological damage and was discharged on day 26 after the above procedure. Conclusions: Idiopathic PVT is often associated with VTE, and a prompt diagnosis and intervention may result in a good prognosis.